Ibex Medical Analytics
AI-powered Cancer Diagnostics for Pathologists
StartupIbex Medical Analytics is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2016. AI-powered Cancer Diagnostics for Pathologists. The company has raised a total of $116.6M across 5 funding rounds, currently at the C stage. Ibex Medical Analytics was founded by Joseph (Yossi) Mossel and Chaim Linhart. Key investors include 83North, Sienna Venture Capital, aMoon Fund, among 10 total investors. The company has 51-200 employees. Core technologies: Artificial Intelligence, Machine Learning, Computer Vision.
With $116.6M in total funding, Ibex Medical Analytics is a C-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageC
- ProductReleased
- ModelB2B
- Employees51-200
- HQTel Aviv-Yafo
- DistrictCenter District
- Last Round$55M
- 83NorthLead
- Sienna Venture Capital
- aMoon Fund
10 investors total
Joseph (Yossi) MosselCo-founder & CEO
Chaim LinhartCo-founder & CTO
36 articles covered by sources including www.calcalistech.com,
www.prnewswire.com,
www.massdevice.com,
finance.walla.co.il,
hitconsultant.net.
What does Ibex Medical Analytics do?
Ibex Medical Analytics uses artificial intelligence technology to develop clinical-grade solutions designed to detect cancer as accurately as a human pathologist. The companys Galen platform uses algorithms to analyze images, detect and grade cancer in biopsies, and point to other findings with high clinical importance, helping pathologists to reduce diagnostic error rates and enable a more efficient workflow. Deployed worldwide, Ibexs Galen Prostate and Galen Breast are AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases. In addition, the company is developing computational prognostic and predictive tests that will enable enhanced patient population stratification and quicker personalized treatment selection.
How much funding has Ibex Medical Analytics raised?
Ibex Medical Analytics has raised $116.6M in total funding across 5 rounds. The company is currently at the C stage. Key investors include 83North, Sienna Venture Capital, aMoon Fund.
Who founded Ibex Medical Analytics?
Ibex Medical Analytics was founded in 2016 by Joseph (Yossi) Mossel (Co-founder & CEO), Chaim Linhart (Co-founder & CTO).
What sector is Ibex Medical Analytics in?
Ibex Medical Analytics operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, Medical Decision Support, with core technologies in Artificial Intelligence, Machine Learning, Computer Vision. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Laboratories, Consumers, Demographics & Family, Women.
Where is Ibex Medical Analytics located?
Ibex Medical Analytics is based in Rokach Boulevard 97, Tel Aviv-Yafo, Israel, Center District.